Hiki i ka ScreenPoint Medical's Transpara AI hoʻoholo hoʻoholo ke kōkua i nā radiologists e ʻike i nā maʻi maʻi umauma ma mua a me ka wikiwiki, e like me kahi noiʻi hou i paʻi ʻia ma Radiology. Ua hoʻohana mua ʻia ka polokalamu e pili ana i nā hōʻike hōʻike honua ma nā ʻāina he 30 a me ka USA, Farani, Kelemānia a me Sepania.
Ke piʻi nei ka nui o ka maʻi kanesa o ka umauma ma ka honua holoʻokoʻa ma muli o ke kaiapuni, ka meaʻai a me ka loli ʻana o ke ʻano o ka nohona akā ke piʻi nei, ke hōʻike nei nā ʻāina i ka hemahema o nā radiologists umauma. Ma UK a me nā ʻāina ʻē aʻe, heluhelu ʻia kēlā me kēia mammogram e ʻelua kauka loea. Eia nō naʻe, he pipiʻi kēia a ma nā wahi ʻē aʻe e hana hoʻokahi wale nō nā radioologists. Ma US no ka laʻana, 60% o nā radiologists e heluhelu ana i nā mammograms he radiologists maʻamau.
Ua ʻike ʻia ʻo ka holoʻokoʻa, a hiki i ka 25% o nā maʻi maʻi maʻi umauma i nalo ʻia e ka nānā ʻana a manaʻo ʻia e ʻike ʻia ma hope. ʻO ka loaʻa mua ʻana o kahi maʻi kanesa, ʻo ka hiki ke mālama mua ʻia ka mea maʻi a ʻoi aku ka nui o ka manawa e ola ai i ka maʻi.
Ua noiʻi kēia noiʻi hou ma luna o 2,000 mau maʻi maʻi maʻi i hala i ka manawa o ka nānā ʻana. Ua hiki iā Transpara ke hoʻomaopopo kūʻokoʻa a hiki i ka 37.5% o kēia mau hoʻokolohua.
Ua ʻōlelo ʻo Polofesa Nico Karssemeijer, ka Luna Hoʻokele o ScreenPoint Medical: "Pōmaikaʻi mākou i ka hana ʻana me nā kauka lapaʻau alakaʻi i ke kula e noiʻi i ka umauma AI a hoʻomaopopo i kona ikaika a me nā palena. Paʻa mākou e kākoʻo i nā haʻawina e hāʻawi ana i nā hōʻike lapaʻau i hiki iā mākou ke hoʻolauna palekana i kā mākou ʻenehana. Ke hōʻoia nei kēia haʻawina nui i ka hiki o AI ke hoʻomaikaʻi i ka ʻike mua ʻana o nā maʻi maʻi maʻi. He mea hoʻololi pāʻani maoli kēia a hōʻike i nā radioologists e hana pū me AI hiki ke hoʻomaikaʻi nui i ka mālama maʻi. "
Ua hoʻohui ʻo Professor Carla van Gils o ke Kulanui Lapaʻau o ke Kulanui, nāna i alakaʻi i ka hoʻokolokolo DENSE ma Netherlands a ʻo ia kekahi o nā mea kākau o ka pepa: "Ma kēia noiʻi ʻana, hoʻohui ʻia ʻo AI i ke ana ʻana o ka umauma i alakaʻi i kahi hoʻomaikaʻi nui i ka hoʻoholo ʻana i ka pilikia he maʻi ʻaʻai waena. Hiki i ka hui pū ʻana o nā ʻano hana ke kōkua iā mākou e kuhikuhi i ka hui o nā poʻe i komo i ka nānā ʻana i ka umauma e pōmaikaʻi nui ʻia mai ka hōʻike ʻana i ka MRI hoʻohui, e pili ana i ka hōʻemi ʻana i nā maʻi maʻi maʻi.
Ua ʻike ʻia ka haʻawina ma ka hoʻohui ʻana i ka mālama umauma Transpara me ka nui o ka umauma, ʻo ia ka mea i ʻike nui ʻia, hiki ke hōʻea i ka 51% o nā wahine i loaʻa i ka maʻi kanesa i ka wā ma hope o ka nānā ʻana. He hana koʻikoʻi kēia i ka hoʻohana ʻana iā Transpara AI no ke ana ʻana i ka pilikia no ka wā pōkole.
He aha e lawe ʻia mai kēia ʻatikala:
- The study found that by combining Transpara breast care with breast density, which is a well known risk factor, it was possible to flag up to 51% of women diagnosed with cancer in the interval after a negative screening.
- The earlier a cancer is discovered, the earlier a patient can be treated and the greater the chance of surviving the disease.
- Professor Carla van Gils of University Medical Center, who led the DENSE trial in the Netherlands and who is one of the authors of the paper, added.
